Article Details
Retrieved on: 2024-01-09 15:15:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Libtayo is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary ...
Article found on: pipelinereview.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here